أعرض تسجيلة المادة بشكل مبسط

dc.contributor Zabriskie, Mark
dc.contributor Gerwick, Bill
dc.date 2006-07-07T15:08:23Z
dc.date 2006-07-07T15:08:23Z
dc.date 2006-07-07T15:08:23Z
dc.date.accessioned 2013-10-16T07:38:30Z
dc.date.available 2013-10-16T07:38:30Z
dc.date.issued 2013-10-16
dc.identifier http://hdl.handle.net/1957/2323
dc.identifier.uri http://koha.mediu.edu.my:8181/xmlui/handle/1957/2323
dc.description Dental disease is a very prevalent and costly disease in which the symptoms, not the disease, are currently being treated. The disease is caused by pathogenic oral bacteria, many of which are a part of the Mutans Streptococci. The objective of this thesis was to find a natural substance that is antibacterial towards the Mutans Streptococci and could have possible uses as a dental disease inhibitor. Crude and prefractionated extracts, as well as purified compounds, from marine organisms were screened against Streptococcus mutans and Streptococcus sobrinus for antibacterial activity using standard antibiotic susceptibility testing. Several antibacterial extracts were identified as well as one very potent pure compound, allolaurinterol. The Minimum Inhibitory Concentration (MIC) of allolaurinterol against Streptococcus mutans and Streptococcus sobrinus was found to be 5 µg/mL and the Minimum Bactericidal Concentration (MBC) was found to be 10 µg/mL. Once the mammalian cell cytotoxicity is determined, the therapeutic window will be known and the possible use of allolaurinterol as a consumer product can be explored.
dc.language en_US
dc.subject Dental disease
dc.subject Antibacterial agents
dc.title Discovery and identification of antibacterial agents for dental use
dc.type Thesis


الملفات في هذه المادة

الملفات الحجم الصيغة عرض

لا توجد أي ملفات مرتبطة بهذه المادة.

هذه المادة تبدو في المجموعات التالية:

أعرض تسجيلة المادة بشكل مبسط